AKBULUT, H. Et Al. 2018. The trough levels of bevacizumab significantly affect the outcome of the treatment in patients with metastatic colorectal cancer: A Turkish Oncology Group study.. JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15 .

AKBULUT, H., Ocal, M., Sonugur, F. G., Abgarmi, S. A., BABAHAN, C., Akay, B., ... Arslan, U. Y.(2018). The trough levels of bevacizumab significantly affect the outcome of the treatment in patients with metastatic colorectal cancer: A Turkish Oncology Group study.. JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15.

AKBULUT, HAKAN Et Al. "The trough levels of bevacizumab significantly affect the outcome of the treatment in patients with metastatic colorectal cancer: A Turkish Oncology Group study.," JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15, 2018

AKBULUT, HAKAN Et Al. "The trough levels of bevacizumab significantly affect the outcome of the treatment in patients with metastatic colorectal cancer: A Turkish Oncology Group study.." JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15, 2018

AKBULUT, H. Et Al. (2018) . "The trough levels of bevacizumab significantly affect the outcome of the treatment in patients with metastatic colorectal cancer: A Turkish Oncology Group study.." JOURNAL OF CLINICAL ONCOLOGY , vol.36, no.15.

@article{article, author={HAKAN AKBULUT Et Al. }, title={The trough levels of bevacizumab significantly affect the outcome of the treatment in patients with metastatic colorectal cancer: A Turkish Oncology Group study.}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2018}